ITT - Advanced Medical Technologies
ITT – Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. ITT aims to transform scientific developments in the area of biotechnology, especially genetics and genomics, into products and services that improves human health, quality of life and performance, and extends life span.
GENAR Biotechnology and Molecular Genetics Research and Implementation Laboratories are established by ITT in Hacettepe University Science Park in 2005. GENAR is the first high-throughput molecular genetic analysis laboratory of Turkey and with its technical infrastructure, the most developed genetic analysis laboratory in the region.
GENAR is equipped with high throughput SNP genotyping facilities, including a special MALDI-TOF based mass spectrometer (MassARRAY system by Sequenom). MassARRAY system is a flexible platform where new assay designs can be rapidly made and optimized. GENAR also has sequencing facilities with a DNA Sequencer based on capillary electrophoreses (MegaBace system by Amersham Biosciences). MegaBace is a 96 capillary platform.
GENAR is a partner of an EU funded FP6 integrated project called EPICURE - Functional Genomics and Neurobiology of Epilepsy, which aims to develop new therapeutic strategies for epilepsy treatment. GENAR will contribute to this project by carrying out genotyping on approximately 2000 samples collected from Europe.
TOGEN – Center for Public Health Genomics and Personalized Medicine is established in Hacettepe Science Park, by ITT. The mission of TOGEN is to catalyse transfer of developments in genetics to the health of individuals with a public health vision. TOGEN is the third public health genomics center in Europe and a cooperating institute of PHGEN – Public Health Genomics European Network.
GENAR - Biotechnology and Molecular Genetics Laboratories
Hacettepe Univ. Science Park (Teknokent) Kulucka Merkezi No:10,